Investing.com - Zimmer Biomet reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Zimmer Biomet announced earnings per share of $1.82 on revenue of $1.78B. Analysts polled by Investing.com anticipated EPS of $1.64 on revenue of $1.72B.
Zimmer Biomet shares are down 39.54% from the beginning of the year, still down 33.59% from its 52 week high of $165.28 set on August 2, 2021. They are under-performing the S&P 500 which is down 13.59% from the start of the year.
Zimmer Biomet follows other major Healthcare sector earnings this month
Zimmer Biomet's report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar